Majedie Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200,060
Closed -$23.6M 85
2021
Q1
$23.6M Sell
200,060
-34,009
-15% -$3.99M 1.71% 16
2020
Q4
$27.4M Sell
234,069
-51,876
-18% -$5.71M 2.1% 11
2020
Q3
$29.7M Sell
285,945
-6,471
-2% -$650K 2.21% 9
2020
Q2
$26.8M Buy
292,416
+153,503
+111% +$14.7M 2.05% 10
2020
Q1
$12.6M Buy
+138,913
New +$14.8M 1.16% 17

Other funds holding MDT

Majedie Asset Management's MDT Position: Q2 2021 in Review

Majedie Asset Management sold out of Medtronic (MDT) in Q2 2021, closing a stake of 200,060 shares — an estimated $23.6M sold.

Majedie Asset Management first reported a position in MDT in Q1 2020 and held it in 5 quarters. The position peaked at $29.7M in Q3 2020. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • Majedie Asset Management reported no remaining Medtronic position as of Q2 2021 after selling out during the quarter.
  • Majedie Asset Management sold 200,060 Medtronic shares in Q2 2021, an estimated $23.6M.
  • Majedie Asset Management first reported a position in Medtronic in Q1 2020 and held it in 5 quarters.
  • Majedie Asset Management's Medtronic position peaked at $29.7M in Q3 2020.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Majedie Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.